Literature DB >> 24990416

Genetic and antigenic evolution of H9N2 avian influenza viruses circulating in Egypt between 2011 and 2013.

Ahmed Kandeil1, Rabeh El-Shesheny, Asmaa M Maatouq, Yassmin Moatasim, Mahmoud M Shehata, Ola Bagato, Adam Rubrum, Karthik Shanmuganatham, Richard J Webby, Mohamed Ahmed Ali, Ghazi Kayali.   

Abstract

Avian influenza virus subtype H9N2 has been circulating in the Middle East since the 1990s. For uncertain reasons, H9N2 was not detected in Egyptian farms until the end of 2010. Circulation of H9N2 viruses in Egyptian poultry in the presence of the enzootic highly pathogenic H5N1 subtype adds a huge risk factor to the Egyptian poultry industry. In this study, 22 H9N2 viruses collected from 2011 to 2013 in Egypt were isolated and sequenced. The genomic signatures and protein sequences of these isolates were analyzed. Multiple mammalian-host-associated mutations were detected that favor transmission from avian to mammalian hosts. Other mutations related to virulence were also identified. Phylogenetic data showed that Egyptian H9N2 viruses were closely related to viruses isolated from neighboring Middle Eastern countries, and their HA gene resembled those of viruses of the G1-like lineage. No reassortment was detected with H5N1 subtypes. Serological analysis of H9N2 virus revealed antigenic conservation among Egyptian isolates. Accordingly, continuous surveillance that results in genetic and antigenic characterization of H9N2 in Egypt is warranted.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24990416      PMCID: PMC4206084          DOI: 10.1007/s00705-014-2118-z

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  59 in total

1.  MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods.

Authors:  Koichiro Tamura; Daniel Peterson; Nicholas Peterson; Glen Stecher; Masatoshi Nei; Sudhir Kumar
Journal:  Mol Biol Evol       Date:  2011-05-04       Impact factor: 16.240

2.  Concepts and applications for influenza antigenic cartography.

Authors:  Zhipeng Cai; Tong Zhang; Xiu-Feng Wan
Journal:  Influenza Other Respir Viruses       Date:  2011-05       Impact factor: 4.380

3.  Phylogeography and evolutionary history of reassortant H9N2 viruses with potential human health implications.

Authors:  Alice Fusaro; Isabella Monne; Annalisa Salviato; Viviana Valastro; Alessia Schivo; Nadim Mukhles Amarin; Carlos Gonzalez; Mahmoud Moussa Ismail; Abdu-Rahman Al-Ankari; Mohamed Hamad Al-Blowi; Owais Ahmed Khan; Ali Safar Maken Ali; Afshin Hedayati; Juan Garcia Garcia; Ghulam M Ziay; Abdolhamid Shoushtari; Kassem Nasser Al Qahtani; Ilaria Capua; Edward C Holmes; Giovanni Cattoli
Journal:  J Virol       Date:  2011-06-15       Impact factor: 5.103

4.  Glycan shielding of the influenza virus hemagglutinin contributes to immunopathology in mice.

Authors:  Keith Wanzeck; Kelli L Boyd; Jonathan A McCullers
Journal:  Am J Respir Crit Care Med       Date:  2010-10-08       Impact factor: 21.405

5.  Complete genome characterization of avian influenza virus subtype H9N2 from a commercial quail flock in Egypt.

Authors:  Abdel-Satar Arafa; Naglaa Hagag; Ahmed Erfan; Wessam Mady; Mohamed El-Husseiny; Amany Adel; Soad Nasef
Journal:  Virus Genes       Date:  2012-06-30       Impact factor: 2.332

6.  Influenza A virus NS1 gene mutations F103L and M106I increase replication and virulence.

Authors:  Samar K Dankar; Shuai Wang; Jihui Ping; Nicole E Forbes; Liya Keleta; Yishan Li; Earl G Brown
Journal:  Virol J       Date:  2011-01-12       Impact factor: 4.099

7.  Avian influenza H9N2 seroprevalence among poultry workers in Pune, India, 2010.

Authors:  Shailesh D Pawar; Babasaheb V Tandale; Chandrashekhar G Raut; Saurabh S Parkhi; Tanaji D Barde; Yogesh K Gurav; Sadhana S Kode; Akhilesh C Mishra
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

8.  Mouse-adapted H9N2 influenza A virus PB2 protein M147L and E627K mutations are critical for high virulence.

Authors:  Jingjing Wang; Yipeng Sun; Qi Xu; Yuanyuan Tan; Juan Pu; Hanchun Yang; Earl G Brown; Jinhua Liu
Journal:  PLoS One       Date:  2012-07-10       Impact factor: 3.240

9.  Continuing threat of influenza (H5N1) virus circulation in Egypt.

Authors:  Ghazi Kayali; Rabeh El-Shesheny; Mohamed A Kutkat; Ahmed M Kandeil; Ahmed Mostafa; Mariette F Ducatez; Pamela P McKenzie; Elena A Govorkova; Mohamed H Nasraa; Robert G Webster; Richard J Webby; Mohamed A Ali
Journal:  Emerg Infect Dis       Date:  2011-12       Impact factor: 6.883

10.  Seroprevalence of antibodies to avian influenza A (H5) and A (H9) viruses among market poultry workers, Hanoi, Vietnam, 2001.

Authors:  Timothy M Uyeki; Doan C Nguyen; Thomas Rowe; Xiuhua Lu; Jean Hu-Primmer; Lien P Huynh; Nguyen L K Hang; Jacqueline M Katz
Journal:  PLoS One       Date:  2012-08-21       Impact factor: 3.240

View more
  30 in total

1.  Mutation signature in neuraminidase gene of avian influenza H9N2/G1 in Egypt.

Authors:  Zienab Mosaad; Abdelsatar Arafa; Hussein A Hussein; Mohamed A Shalaby
Journal:  Virusdisease       Date:  2017-05-23

Review 2.  Epidemiology, ecology and gene pool of influenza A virus in Egypt: will Egypt be the epicentre of the next influenza pandemic?

Authors:  E M Abdelwhab; Ahmed S Abdel-Moneim
Journal:  Virulence       Date:  2015       Impact factor: 5.882

Review 3.  H9 Influenza Viruses: An Emerging Challenge.

Authors:  Silvia Carnaccini; Daniel R Perez
Journal:  Cold Spring Harb Perspect Med       Date:  2020-06-01       Impact factor: 6.915

4.  Generation of a reassortant avian influenza virus H5N2 vaccine strain capable of protecting chickens against infection with Egyptian H5N1 and H9N2 viruses.

Authors:  Ahmed Kandeil; Yassmin Moatasim; Mokhtar R Gomaa; Mahmoud M Shehata; Rabeh El-Shesheny; Ahmed Barakat; Richard J Webby; Mohamed A Ali; Ghazi Kayali
Journal:  Vaccine       Date:  2015-11-25       Impact factor: 3.641

5.  Novel reassortant H9N2 viruses in pigeons and evidence for antigenic diversity of H9N2 viruses isolated from quails in Egypt.

Authors:  Ahmed Kandeil; Rabeh El-Shesheny; Asmaa Maatouq; Yassmin Moatasim; Zhipeng Cai; Pamela McKenzie; Richard Webby; Ghazi Kayali; Mohamed A Ali
Journal:  J Gen Virol       Date:  2017-05-05       Impact factor: 3.891

6.  In-silico evidence for enhancement of avian influenza virus H9N2 virulence by modulation of its hemagglutinin (HA) antigen function and stability during co-infection with infectious bronchitis virus in chickens.

Authors:  Mohammed A AboElkhair; Mohamed E Hasan; Ahmed Mousa; Ibrahim Moharam; Hesham Sultan; Yashpal Malik; Moustafa A Sakr
Journal:  Virusdisease       Date:  2021-09-07

7.  Protective efficacy of combined trivalent inactivated ISA 71 oil adjuvant vaccine against avian influenza virus subtypes (H9N2 and H5N1) and Newcastle disease virus.

Authors:  Zeinab Mohamed Ali; Mervat Abd El Monaem Hassan; Hussein Ali Hussein; Basem Mohamed Ahmed; Ahmed Abd El-Ghany El Sanousi
Journal:  Vet World       Date:  2017-10-11

Review 8.  A brief summary of the epidemiology and genetic relatedness of avian influenza H9N2 virus in birds and mammals in the Middle East and North Africa.

Authors:  A Nagy; T C Mettenleiter; E M Abdelwhab
Journal:  Epidemiol Infect       Date:  2017-11-23       Impact factor: 4.434

9.  Household Transmission of Zoonotic Influenza Viruses in a Cohort of Egyptian Poultry Growers.

Authors:  Amira S El Rifay; Mona A Elabd; Dina Abu Zeid; Mokhtar R Gomaa; Li Tang; Pamela P McKenzie; Richard J Webby; Mohamed A Ali; Ghazi Kayali
Journal:  JMIR Res Protoc       Date:  2015-06-22

10.  Ecosystem Interactions Underlie the Spread of Avian Influenza A Viruses with Pandemic Potential.

Authors:  Justin Bahl; Truc T Pham; Nichola J Hill; Islam T M Hussein; Eric J Ma; Bernard C Easterday; Rebecca A Halpin; Timothy B Stockwell; David E Wentworth; Ghazi Kayali; Scott Krauss; Stacey Schultz-Cherry; Robert G Webster; Richard J Webby; Michael D Swartz; Gavin J D Smith; Jonathan A Runstadler
Journal:  PLoS Pathog       Date:  2016-05-11       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.